Comparing Short-Term Dual vs Standard Quadruple Therapy for Helicobacter pylori Eradication
- PMID: 39016395
- DOI: 10.14309/ajg.0000000000002882
Comparing Short-Term Dual vs Standard Quadruple Therapy for Helicobacter pylori Eradication
References
-
- Yan T-L, Wang J-H, He X-J, et al. Ten-day vonoprazan-amoxicillin dual therapy vs standard 14-day bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: A multicenter randomized clinical trial. Am J Gastroenterol 2024;119(4):655–61.
-
- Fallone CA, Chiba N, van Zanteri SV, et al. The Toronto consensus for treatment of Helicobacter pylori infection in adults. Gastroenterology 2016;15(1):51–69.e14.
-
- Ierardi E, Losurdo G, Fortezza RF, et al. Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness. World J Gastroenterol 2019;25(34):5097–104.
-
- Zagari RM, Romano M, Ojetti V, et al. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. Dig Liver Dis 2015;47:903–12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
